April 30, 2019
Allotex begins with final phase of Presbyopia clinical trials
Allotex has treated over 50 eyes in the first phase of its clinical trials.
Pharmaceuticals, Biotechnology and Life Sciences
Allotex has treated over 50 eyes in the first phase of its clinical trials.